ISPOR Lebanon Chapter held their successful annual meeting on Friday 24, 2017 at Hilton Beirut Habtoor Grand, Beirut-Lebanon. The goal of the meeting program for this annual meeting was, to provide key concepts in Budget Impact Analysis (BIA), which is a tool to predict the financial impact of the adoption and diffusion of a new technology and is increasingly required, along with cost-effectiveness analysis (CEA), prior to formulary approval of reimbursement. The purpose of BIA is to estimate the financial consequences of adoption and diffusion of a new health care intervention within a specific health care setting or system context given inevitable resource constraints.
Target audience: governmental and private institutions. This includes Ministry of Public Health, National Social Security, Military, hospital pharmacists, Pharmaceutical and Biotech companies, insurance companies, and academicians in Lebanon and MENA region.
This two-day workshop organized by the members of the newly developed ISPOR Lebanon Chapter, focused on the basic principles and processes of Pharmacoeconomics (PE) and applications leading to the improvement of drug formulary development in Middle East countries. Presenters analyzed pharmacoeconomic strategies and outcomes research to determine relative drug adoption guidelines.
The educational objectives of this workshop included:
Speakers included Dr. Ibrahim Al-Abbadi, Chair of ISPOR Arabic Network, Dr. Abdulaziz Al-Saggabi, Chair-Elect of ISPOR Arabic Network and the Chair of ISPOR CEE Network Executive Committee, Prof. Zoltan Kalo. For details, please see Program.
|President||Ghassan Hamadeh, MD|
|President-elect||Mirna Metni, PharmD|
|Secretary||Soumana Nasser, PharmD|
|Treasurer||Marie-Therese Sawaya, MD|
|Director of Communications||Maher Hassoun, MS|
Contact InformationISPOR Lebanon Regional Chapter Office